CRISPR/Cas9 Genome Editing in the Diamondback Moth: Current Progress, Challenges, and Prospects

被引:0
|
作者
Asad, Muhammad [1 ,2 ,3 ,4 ,5 ]
Chang, Yanpeng [1 ,2 ,3 ,4 ,5 ]
Liao, Jianying [1 ,2 ,3 ,4 ,5 ]
Yang, Guang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Agr & Forestry Biosecur, Fuzhou 350002, Peoples R China
[2] Minist Educ, Joint Int Res Lab Ecol Pest Control, Fuzhou 350002, Peoples R China
[3] Fujian Agr & Forestry Univ, Ministerial & Prov Joint Innovat Ctr Safety Prod C, Fuzhou 350002, Peoples R China
[4] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan C, Fuzhou 350002, Peoples R China
[5] Fujian Prov Univ, Key Lab Green Pest Control, Fuzhou 350002, Peoples R China
关键词
site-directed mutagenesis; genetic control; efficiency of CRISPR/Cas9 system; Plutella xylostella; gene drive; genetic modification; HOMOLOGY-DIRECTED REPAIR; GENE DRIVE SYSTEMS; CRISPR-CAS9; EFFICIENCY; IDENTIFICATION; ENDONUCLEASE; STRATEGIES; BIOLOGY;
D O I
10.3390/ijms26041515
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of site-specific genome-editing tools like CRISPR (clustered regularly interspaced short palindromic repeat) and its associated protein, Cas9, is revolutionizing genetic engineering with its highly efficient mechanism, offering the potential for effective pest management. Recently, CRISPR/Cas9 gene-editing has been extensively utilized in the management of the diamondback moth, Plutella xylostella (L.), a highly destructive pest of vegetable crops, for different purposes, such as gene function analysis and genetic control. However, the progress related to this gene-editing tool in P. xylostella has not yet been summarized. This review highlights the progress and applications of CRISPR/Cas9 in uncovering the genes critical for development, reproduction, and insecticide resistance in P. xylostella. Moreover, the progress related to the CRISPR/Cas9 gene drive for population suppression and modifications has also been discussed. In addition to the significant progress made, challenges such as low germline editing efficiency and limited homology-directed repair remain obstacles to its widespread application. To address these limitations, we have discussed the different strategies that are anticipated to improve the efficiency of CRISPR/Cas9, paving the way to it becoming a pivotal tool in sustainable pest management. Therefore, the present review will help researchers in the future enhance the efficiency of the CRISPR/Cas9 system and use it to manage the diamondback moth.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] CRISPR/CAS9: THE GOLD STANDARD OF GENOME EDITING?
    Gleeson, Alfie
    Sawyer, Abigail
    BIOTECHNIQUES, 2018, 64 (06) : 239 - 244
  • [32] CRISPR/Cas9 and other techniques for genome editing
    Hartung, Frank
    Schiemann, Jochen
    Sprink, Thorben
    ZWEITES SYMPOSIUM ZIERPFLANZENZUCHTUNG, 2017, 2017, 457 : 36 - 39
  • [33] Genome Editing in Cotton with the CRISPR/Cas9 System
    Gao, Wei
    Long, Lu
    Tian, Xinquan
    Xu, Fuchun
    Liu, Ji
    Singh, Prashant K.
    Botella, Jose R.
    Song, Chunpeng
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [34] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [35] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [36] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [37] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [38] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [39] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [40] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):